AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 71(2), 2004, pp. 196-201
Copyright © 2004 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HERMSEN, C. C.
Right arrow Articles by SAUERWEIN, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HERMSEN, C. C.
Right arrow Articles by SAUERWEIN, R. W.
Related Collections
Right arrow Malaria
Right arrow Modeling

TESTING VACCINES IN HUMAN EXPERIMENTAL MALARIA: STATISTICAL ANALYSIS OF PARASITEMIA MEASURED BY A QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION

CORNELUS C. HERMSEN, SAKE J. DE VLAS, GEERT JAN A. VAN GEMERT, DENISE S. C. TELGT, DANIELLE F. VERHAGE, AND ROBERT W. SAUERWEIN
Departments of Medical Microbiology and Internal Medicine, University Medical Center, Nijmegen, The Netherlands; Department of Public Health, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands

Clinical trials are an essential step in evaluation of safety and efficacy of malaria vaccines, and human experimental malaria infections have been used for evaluation of protective immunity of Plasmodium falciparum malaria. In this study, a quantitative real-time polymerase chain reaction was used to measure P. falciparum malaria parasitemia in non-immune volunteers who had been experimentally infected by mosquito bites. Based on a remarkably small variation in the kinetics of parasitemia, a statistical model was developed that provides detailed estimates of pre-patent periods and parasite multiplication of blood stages. Using this model, we could predict results on vaccine efficacy for 1) pre-erythrocytic vaccines in the asymptomatic incubation period and 2) asexual stage vaccines after a limited number of multiplication cycles. The model shows that stage-specific vaccines even with limited efficacy can be highly efficacious when used in combination. This P. falciparum challenge method significantly adds to the potential to evaluate efficacy of candidate malaria vaccines before going into field trials.

Received January 13, 2004. Accepted for publication March 16, 2004.

Acknowledgments: We thank M. van de Vegte-Bolmer for culturing malaria parasites, T. Arens and M. Sieben for skilled microscopy, J. van der Meer for clinical assistance, N. Nagelkerke for statistical advice, and W. Eling and A. Thomas for critical review and discussions.

Financial support: This project was supported by the European Union FP 5, contract number QLK2 -CT-1999-01293.

Authors’ addresses: Cornelus C. Hermsen, Geert Jan A. van Gemert, Denise S. C. Telgt, and Robert W. Sauerwein, Department of Medical Microbiology 188, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands, Telephone: 31-24-361-3663, Fax: 31-24-361-4666, E-mails: r.hermsen{at}ncmls.kun.nl, g.vangemert{at}mmb.umcn.nl, d.telgt{at}aig.umcn.nl, and r.sauerwein{at}mmb.umcn.nl. Sake J. de Vlas, Department of Public Health, Erasmus Medical Center, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands, Telephone: 31-10-408-7985/8285, Fax: 31-10-408-9449, E-mail: s.devlas{at}erasmusmc.nl. Danielle F. Verhage, Department of Internal Medicine 541, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands, E-mail: d.verhage{at}aig.umcn.nl.




This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
A. A. Djimde, B. Fofana, I. Sagara, B. Sidibe, S. Toure, D. Dembele, S. Dama, D. Ouologuem, A. Dicko, and O. K. Doumbo
Efficacy, Safety, and Selection of Molecular Markers of Drug Resistance by Two ACTs in Mali
Am J Trop Med Hyg, March 1, 2008; 78(3): 455 - 461.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
Y. Lubell, H. Reyburn, H. Mbakilwa, R. Mwangi, S. Chonya, C. J M Whitty, and A. Mills
The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis
BMJ, January 26, 2008; 336(7637): 202 - 205.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
Y. Lubell, H. Reyburn, H. Mbakilwa, R. Mwangi, K. Chonya, C. J. M. Whitty, and A. Mills
The Cost-Effectiveness of Parasitologic Diagnosis for Malaria-Suspected Patients in an Era of Combination Therapy
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 128 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. A. Magistrado, J. Lusingu, L. S. Vestergaard, M. Lemnge, T. Lavstsen, L. Turner, L. Hviid, A. T. R. Jensen, and T. G. Theander
Immunoglobulin G Antibody Reactivity to a Group A Plasmodium falciparum Erythrocyte Membrane Protein 1 and Protection from P. falciparum Malaria
Infect. Immun., May 1, 2007; 75(5): 2415 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
O. A. MOKUOLU, E. O. OKORO, S. O. AYETORO, and A. A. ADEWARA
EFFECT OF ARTEMISININ-BASED TREATMENT POLICY ON CONSUMPTION PATTERN OF ANTIMALARIALS
Am J Trop Med Hyg, January 1, 2007; 76(1): 7 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. G. BREMAN, M. S. ALILIO, and A. MILLS
CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT'S NEW, WHAT'S NEEDED: A SUMMARY
Am J Trop Med Hyg, August 1, 2004; 71(2_suppl): 1 - 15.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society of Tropical Medicine and Hygiene.